In patients with myelodysplastic syndromes (MDS), MSCs show a decreased expression of certain cell surface molecules [39], especially those involved in the interaction with HSPCs [40], including the adhesion molecules CD44 and CD49e (α5-integrin). Here, ITGA5 is linked to myelodysplastic syndrome.